1. Home
  2. CETY vs CVKD Comparison

CETY vs CVKD Comparison

Compare CETY & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Technologies Inc.

CETY

Clean Energy Technologies Inc.

HOLD

Current Price

$0.99

Market Cap

9.9M

Sector

Utilities

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$2.46

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETY
CVKD
Founded
1993
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
10.3M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
CETY
CVKD
Price
$0.99
$2.46
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$13.00
AVG Volume (30 Days)
27.3K
71.1K
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.94
EPS
N/A
N/A
Revenue
$957,633.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$2.29
52 Week High
$3.05
$14.64

Technical Indicators

Market Signals
Indicator
CETY
CVKD
Relative Strength Index (RSI) 65.33 31.14
Support Level $0.71 N/A
Resistance Level $1.02 $3.89
Average True Range (ATR) 0.08 0.42
MACD 0.01 -0.02
Stochastic Oscillator 92.56 6.56

Price Performance

Historical Comparison
CETY
CVKD

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is a late-stage biopharmaceutical company advancing novel therapies for life-threatening immune and thrombotic conditions. Its product candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor being developed to treat heparin-induced thrombocytopenia (HIT), a deadly immune-mediated thrombotic disorder. The pipeline includes two additional clinical-stage assets: tecarfarin and frunexian. Tecarfarin is an oral vitamin K antagonist (VKA) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients requiring chronic anticoagulation. Frunexian is a first-in-class, Phase 2-ready intravenous Factor XIa inhibitor designed for acute care settings where contact activation of coagulation by medical devices or artificial surfaces.

Share on Social Networks: